CVTOX

Product NDC
43857-0514
11-digit product format
438570514
Labeler code
43857
Product ID
43857-0514_dffc835e-08e8-4ef4-9db8-ebd250033c1b
Type
HUMAN OTC DRUG
Nonproprietary name
Cochlearia Armoracia, Echinacea (Angustifolia), Lomatium Dissectum, Tabebuia Impetiginosa, Hydrastis Canadensis, Propolis, Glandula Suprarenalis Bovine, Thymus (Suis), Aranea Diadema, Ipecacuanha, Lycopodium Clavatum, Muriaticum Acidum, Nitricum Acidum, Phosphoricum Acidum, Rhus Tox, Silicea, Epstein-Barr Virus Nosode, Herpes Zoster Nosode, Morbillinum, Poliomyelitis Nosode, Hepatitis B Nosode, Coxsackie B1 Nosode, Coxsackie B4 Nosode, Cytomegalovirus Nosode
Dosage form
LIQUID
Route
ORAL
Labeler
BioActive Nutritional, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2019-05-14
Marketing end
0000-00-00
Substance
HORSERADISH; ECHINACEA ANGUSTIFOLIA; LOMATIUM DISSECTUM ROOT; TABEBUIA IMPETIGINOSA BARK; GOLDENSEAL; PROPOLIS WAX; BOS TAURUS ADRENAL GLAND; SUS SCROFA THYMUS; ARANEUS DIADEMATUS; IPECAC; LYCOPODIUM CLAVATUM SPORE; HYDROCHLORIC ACID; NITRIC ACID; PHOSPHORIC ACID; TOXICODENDRON PUBESCENS LEAF; SILICON DIOXIDE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 3; MEASLES VIRUS; POLIOVIRUS; HEPATITIS B VIRUS; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B4; HUMAN HERPESVIRUS 5
Active strength
3 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
43857-0514-12023-11-07C16284748780-1ba0f9c33-3102-a910-e053-dadaa90a0b85d7544ca2-6837-41a4-a9cf-ed20ddef9602
43857-0514-12021-01-29C16284748780-1ba0f9c33-3102-a910-e053-dadaa90a0b85d7544ca2-6837-41a4-a9cf-ed20ddef9602